MiRXES eyes fuss-free early cancer tests; road ahead not easy
Local startup, which is heading towards a public listing, is doubling down on its acquisition strategy after a US$77m funding round
Singapore
IMAGINE if early-stage cancer testing was as fuss-free as taking a Covid PCR test or a blood test.
Homegrown startup MiRXES is hoping to bring such "liquid" cancer tests into our homes in about 5 to 10 years' time. If this dream pans out, a simple blood test could be able to detect all types of cancers at an early stage - when it is easier to treat and possibly cure.
TRENDING NOW
Ohmyhome Ltd sells real estate business for token US$1 due to poor business and continued losses
Buyer for England striker Harry Kane’s former mansion must pay £3.4 million after abandoning deal
Real estate firm Ohmyhome’s journey over the past 10 years
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan